Skip to content
DraconiticResearch
Search Sources API
190,335 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BYJournal of translational internal medicine

Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition

  1. 1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Related

  1. Prognostic Value of Serial Alkaline Phosphatase-to-Albumin Ratio for Mortality After Transjugular Intrahepatic Portosystemic Shunt
    Sadik Yavuz, Ezgi Comoglu, Derya Ari +3
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Early Prognostic Value of the Freiburg Index of Post-Transjugular Intrahepatic Portosystemic Shunt Survival in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation
    Yifan Ling, Jiaxin Zhao, Mengni Jing +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Clot Out, Flow Back: Large-Bore Aspiration Thrombectomy for Symptomatic Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Occlusion.
    Renato Abu Hana, Ryosuke Miyauchi, Yusuf Alzoubi +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Reevaluating hypercoagulability in the portal vein and the impact of transjugular intrahepatic portosystemic shunt on platelet activation in cirrhosis
    Viktoria Möller, Anselm Kunstein, Christian Weigel +10
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
  5. Inhibition of the ZEB1–BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma
    Ester Gonzalez-Sanchez, Marie Vallette, Lucia Garcia-Collado +15
    Biomedicine and PharmacotherapyPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaHAL
BibTeX
@article{ye2026dualpathway,
  title = {{Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition}},
  author = {Yanting Ye and Zhiyin Huang and Jinhang Gao and Chengwei Tang},
  journal = {Journal of translational internal medicine},
  year = {2026},
  month = aug,
  doi = {10.1515/jtim-2026-0077},
  url = {https://europepmc.org/article/PMC/PMC13726661},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
AU  - Yanting Ye
AU  - Zhiyin Huang
AU  - Jinhang Gao
AU  - Chengwei Tang
PY  - 2026
DA  - 2026/08/24
JO  - Journal of translational internal medicine
DO  - 10.1515/jtim-2026-0077
UR  - https://europepmc.org/article/PMC/PMC13726661
SN  - 2450-131X
SN  - 2224-4018
ER  -